Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

CBL1304 Anti-Integrin α4 Antibody, clone PS/2

CBL1304
500 µg  
Purchase on Sigma-Aldrich

Offerte speciali

Panoramica

Replacement Information

Offerte speciali

Tabella delle specifiche principali

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, MFC, IF, IP, IHC, FUNCRPurifiedMonoclonal Antibody
Description
Catalogue NumberCBL1304
Replaces04-1131
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Integrin α4 Antibody, clone PS/2
Alternate Names
  • CD49d
  • VLA-4
Background InformationVirtually all lymphoid and myeloid cells in bone marrow are reactive with the anti-VLA-4 antibody. VLA-4 is absent or minimally detectable on stromal cells. Myeloid cells maintained in Dexter-type long-term cultures of murine bone marrow are positive, as are lymphoid cells from Whitlock-White cultures.
References
Product Information
FormatPurified
PresentationPurified rat IgG2bκ in 0.01 M phosphate buffer, pH 7.1 containing no preservatives.
Quality LevelMQ100
Applications
ApplicationAnti-Integrin α4 Antibody, clone PS/2 detects level of Integrin α4 & has been published & validated for use in FC, IF, IP, IH.
Key Applications
  • Flow Cytometry
  • Immunofluorescence
  • Immunoprecipitation
  • Immunohistochemistry
  • Affects Function
Application NotesFlow cytometry: 2 μg per 106 cells

Immunohistochemistry on frozen tissue sections

Immunoprecipitation

Cell adhesion assays

Optimal working dilutions must be determined by the end user.
Biological Information
ClonePS/2
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRat
SpecificityClone PS/2 recognises the murine alpha4 chain of the VLA-4 integrin heterodimer, 150 kDa. The antibody also reacts with human VLA-4.
IsotypeIgG2bκ
Species Reactivity
  • Human
  • Mouse
Species Reactivity NoteHuman, Mouse. Reactivity with other species has not been confirmed.
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThe product of this gene belongs to the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. This gene encodes an alpha 4 chain. Unlike other integrin alpha chains, alpha 4 neither contains an I-domain, nor undergoes disulfide-linked cleavage. Alpha 4 chain associates with either beta 1 chain or beta 7 chain.
Gene Symbol
  • ITGA4
  • IA4
  • MGC90518
  • VLA-4
  • CD49D
  • CD49d
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P13612 # Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. They are also receptors for VCAM1. Integrin alpha- 4/beta-1 recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha- 4/beta-7 is also a receptor for MADCAM1. It recognizes the sequence L-D-T in MADCAM1. On activated endothelial cells integrin VLA-4 triggers homotypic aggregation for most VLA-4-positive leukocyte cell lines. It may also participate in cytolytic T-cell interactions with target cells.
SIZE: 1038 amino acids; 115333 Da
SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha subunit can sometimes be cleaved into two non-covalently associated fragments. Alpha-4 associates with either beta-1 or beta-7. Alpha-4 interacts with PXN, LPXN, and TGFB1I1/HIC5. Interacts with CSPG4 through CSPG4 chondroitin sulfate glycosaminoglycan.
SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
DOMAIN: SwissProt: P13612 The SG1 motif is involved in binding to chondroitin sulfate glycosaminoglycan and cell adhesion.
PTM: Phosphorylation on Ser-1027 inhibits PXN binding.
SIMILARITY: Belongs to the integrin alpha chain family. & Contains 7 FG-GAP repeats.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain at -20ºC for up to 12 months from date of receipt.Upon first use, aliquot into smaller quantities to avoid additional freeze/thaw cycles.
Packaging Information
Material Size500 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
CBL1304 04053252625169

Documentation

Anti-Integrin α4 Antibody, clone PS/2 MSDS

Titolo

Scheda di sicurezza (MSDS) 

Anti-Integrin α4 Antibody, clone PS/2 Certificati d'Analisi

TitoloNumero di lotto
Anti-Integrin α4 Antibody, clone PS/2 - 3301922 3301922
Anti-Integrin α4 Antibody, clone PS/2 - 3539794 3539794
Anti-Integrin α4 Antibody, clone PS/2 - 3543899 3543899
Anti-Integrin α4 Antibody, clone PS/2 - 3776178 3776178
Anti-Integrin α4 Antibody, clone PS/2 - 3928009 3928009
Anti-Integrin α4 Antibody, clone PS/2 -2769898 2769898
Anti-Integrin α4 Antibody, clone PS/2 -2829802 2829802
Anti-Integrin 4 Antibody, clone PS/2 -2783101 2783101
RAT ANTI-MOUSE INTEGRIN alpha4 [CD49d] MONOCLONAL ANTIBODY - 2115974 2115974
RAT ANTI-MOUSE INTEGRIN alpha4 [CD49d] MONOCLONAL ANTIBODY - 2391072 2391072

Riferimenti bibliografici

Panoramica dei riferimenti bibliograficiCodice d'identificazione nel Pub Med
Integrins and cAMP mediate netrin-induced growth cone collapse.
Lemons, ML; Abanto, ML; Dambrouskas, N; Clements, CC; Deloughery, Z; Garozzo, J; Condic, ML
Brain research  1537  46-58  2013

Mostra il sommario
24001590 24001590
Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation
Garmy-Susini, B. et al.
J. Clin. Invest., 115:1542-1551 (2005)  2004

15902308 15902308